Dr.pharmacist
Differin Gel

Differin Gel

adapalene 0.1%

OTC DrugDifferin Gel
Reviewed by Younghun Cho

Pharmacist's Verdict

Differin Gel is a highly effective, dermatologist-recommended acne treatment that offers prescription-strength results over the counter. It's a fantastic first choice for mild to moderate acne, but users must be patient and prepared for initial dryness and irritation.

Ingredient Analysis

Adapalene 0.1%

Carbomer

Propylene Glycol

Pros & Cons

Pros

  • Contains a prescription-strength retinoid (adapalene) without needing a doctor's visit.
  • Treats the root cause of acne by regulating skin cell turnover to prevent clogged pores.
  • Generally better tolerated and less irritating than older retinoids like tretinoin.
  • Can also improve skin texture and reduce the appearance of post-acne marks over time.

Cons

  • Often causes an initial 'purging' phase where acne can temporarily worsen.
  • Common side effects include dryness, redness, peeling, and irritation for the first few weeks.
  • Results are not immediate; it can take 8-12 weeks of consistent daily use to see significant improvement.
  • Increases sun sensitivity, making daily sunscreen use non-negotiable.

References

  1. 1.
    FDA Drug Label — Neutrogena Adapalene 0.1% Acne Treatment

    FDA DailyMed: Neutrogena Adapalene 0.1% Acne Treatment · FDA

  2. 2.
    Guidelines of care for the management of acne vulgaris.

    Reynolds RV, Yeung H, Cheng CE, et al., Journal of the American Academy of Dermatology, 2024 · PubMed

  3. 3.
    Management of Acne Vulgaris: A Review.

    Eichenfield DZ, Sprague J, Eichenfield LF, JAMA, 2021 · PubMed

  4. 4.
    Perioral dermatitis: Diagnosis, proposed etiologies, and management.

    Searle T, Ali FR, Al-Niaimi F, Journal of cosmetic dermatology, 2021 · PubMed

  5. 5.
    Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.

    Dréno B, Layton AM, Troielli P, et al., European journal of dermatology : EJD, 2022 · PubMed

  6. 6.
    Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis.

    Harper JC, Baldwin H, Choudhury SP, et al., Journal of drugs in dermatology : JDD, 2024 · PubMed